Document is current

Any future updates will be listed below

Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway

Crossref DOI link: https://doi.org/10.1007/s10238-025-02009-y

Published Online: 2026-01-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark